Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, Yeming Wang, Xingwang Li, +26

The Lancet

Virus EpidemiologyNovel CoronavirusCovid-19 PandemicEmergent VirusClinical Features +6

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta, Daniel F. McAuley, Michael Brown, +3

The Lancet

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Rudragouda Channappanavar, Anthony R. Fehr, Rahul Vijay, +4

Cell Host & Microbe

InflammationHost ResponseInnate Immune SystemImmunologyImmune Regulation +6

Detection of interferon alpha protein reveals differential levels and cellular sources in disease

Mathieu P. Rodero, Jérémie Decalf, Vincent Bondet, +32

The Journal of Experimental Medicine

Cellular SourcesImmunodeficienciesImmunologyPathologyImmunodominance +28

SARS-CoV-2 sensitive to type I interferon pretreatment.

Kumari G. Lokugamage, Adam Hage, Maren Devries, +5

Viral EvolutionViral DiagnosticsEmerging Infectious DiseasesIfn-i PretreatmentInterferon Antagonist +12

Comparison of RT-qPCR and Nanostring in the measurement of blood interferon response for the diagnosis of type I interferonopathies

Rémi Pescarmona, Alexandre Bélot, Marine Villard, +9

Cytokine

Blood Interferon ResponseMedicineHematologyImmunologyPathology +3

Type I Interferon in Children with Viral or Bacterial Infections

Sophie Trouillet‐Assant, Sébastien Viel, Antoine Ouziel, +9

Clinical Chemistry